Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction - Kitamura, Y; Matsuka, Y; Spigelman, I; Ishihara, Y; Yamamoto, Y; Sonoyama, W (Neuro- science, 2009)
et al.